https://www.acumenresearchandconsulting.com/
Home Services Industry Services Press Releases About Us Blogs Report Store Contact us

Platelet and Plasma Market Size - Global Industry Analysis, Market Share, Opportunities and Forecast 2021 - 2028

Published : Apr 2021

Report ID: ARC2162

Pages : 190

Format : Platelet and Plasma Market Size - Global Industry Analysis, Market Share, Opportunities and Forecast 2021 - 2028

CHAPTER 1.Industry Overview of Platelet and Plasma

1.1.Definition and Scope 

1.1.1.Definition of Platelet and Plasma

1.1.2.Market Segmentation

1.1.3.Years Considered for the Study

1.1.4.Assumptions and Acronyms Used

1.1.4.1.Market Assumptions and Market Forecast

1.1.4.2.Acronyms Used in Global Platelet and Plasma Market

1.2.Summary

1.2.1.Executive Summary 

1.2.2.Platelet and Plasma Market By Component

1.2.3.Platelet and Plasma Market By Distribution Channel

1.2.4.Platelet and Plasma Market By Application

1.2.5.Platelet and Plasma Market by Regions

CHAPTER 2.Research Approach

2.1.Methodology 

2.1.1.Research Programs

2.1.2.Market Size Estimation

2.1.3.Market Breakdown and Data Triangulation

2.2.Data Source

2.2.1.Secondary Sources

2.2.2.Primary Sources

CHAPTER 3.Market Dynamics And Competition Analysis

3.1.Market Drivers

3.1.1.Driver 1

3.1.2.Driver 2

3.2.Restraints and Challenges

3.2.1.Restrain 1

3.2.2.Restrain 2

3.3.Growth Opportunities

3.3.1.Opportunity 1

3.3.2.Opportunity 2 

3.4.Porter’s Five Forces Analysis

3.4.1.Bargaining Power of Suppliers

3.4.2.Bargaining Power of Buyers

3.4.3.Threat of Substitute

3.4.4.Threat of New Entrants

3.4.5.Degree of Competition

3.5.Market Concentration Ratio and Market Maturity Analysis of Platelet and Plasma Market

3.5.1.Go To Market Strategy

3.5.1.1.Introduction

3.5.1.2.Growth

3.5.1.3.Maturity

3.5.1.4.Saturation

3.5.1.5.Possible Development

3.6.Technological Roadmap for Platelet and Plasma Market

3.7.Value Chain Analysis

3.7.1.List of Key Manufacturers 

3.7.2.List of Customers

3.7.3.Level of Integration

3.8.Cost Structure Analysis

3.8.1.Price Trend of Key Raw Materials

3.8.2.Raw Material Suppliers

3.8.3.Proportion of Manufacturing Cost Structure

3.8.3.1.Raw Material

3.8.3.2.Labor Cost

3.8.3.3.Manufacturing Expense

3.9.Regulatory Compliance

3.10.Competitive Landscape, 2020

3.10.1.Player Positioning Analysis

3.10.2.Key Strategies Adopted By Leading Players

CHAPTER 4.Manufacturing Plant Analysis

4.1.Manufacturing Plant Location and Establish Date of Major Manufacturers in 2020

4.2.R&D Status and Application Source of Platelet and Plasma Major Manufacturers in 2020

CHAPTER 5.Platelet and Plasma Market By Component

5.1.Introduction

5.2.Platelet and Plasma Revenue By Component

5.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast, By Component, 2017-2028

5.2.2.Platelets

5.2.2.1.Platelets Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

5.2.3.Plasma

5.2.3.1.Plasma Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 6.Platelet and Plasma Market Revenue By Distribution Channel

6.1.Introduction

6.2.Platelet and Plasma Revenue (US$ Mn) By Distribution Channel

6.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

6.2.2.Hospitals

6.2.2.1.Hospitals Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.3.Ambulatory surgical centers

6.2.3.1.Ambulatory surgical centers Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

6.2.4.Others

6.2.4.1.Others Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 7.Platelet and Plasma Market By Application 

7.1.Introduction

7.2.Platelet and Plasma Revenue (US$ Mn) By Application

7.2.1.Platelet and Plasma Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

7.2.2.Hemophilia

7.2.2.1.Hemophilia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.3.Thrombocytopenia

7.2.3.1.Thrombocytopenia Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.4.Perioperative indications

7.2.4.1.Perioperative indications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.5.Platelet function disorders

7.2.5.1.Platelet function disorders Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.6.Other platelet applications

7.2.6.1.Other platelet applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.7.Coagulation factor deficiencies

7.2.7.1.Coagulation factor deficiencies Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.8.Thrombotic thrombocytopenic purpura

7.2.8.1.Thrombotic thrombocytopenic purpura Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.9.Hemorrhage

7.2.9.1.Hemorrhage Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.10.Liver disease

7.2.10.1.Liver disease Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

7.2.11.Other plasma applications

7.2.11.1.Other plasma applications Market Revenue (US$ Mn) and Growth Rate (%), 2017-2028

CHAPTER 8.North America Platelet and Plasma Market By Country 

8.1.North America Platelet and Plasma Overview

8.2.U.S.

8.2.1.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

8.2.2.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

8.2.3.U.S. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

8.3.Canada

8.3.1.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

8.3.2.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

8.3.3.Canada Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

8.4.North America PEST Analysis

CHAPTER 9.Europe Platelet and Plasma Market By Country

9.1.Europe Platelet and Plasma Market Overview

9.2.U.K.

9.2.1.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

9.2.2.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

9.2.3.U.K. Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.3.Germany

9.3.1.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

9.3.2.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

9.3.3.Germany Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.4.France

9.4.1.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

9.4.2.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

9.4.3.France Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.5.Spain

9.5.1.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

9.5.2.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

9.5.3.Spain Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.6.Rest of Europe

9.6.1.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017-2028

9.6.2.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017-2028

9.6.3.Rest of Europe Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017-2028

9.7.Europe PEST Analysis

CHAPTER 10.Asia Pacific Platelet and Plasma Market By Country

10.1.Asia Pacific Platelet and Plasma Market Overview

10.2.China

10.2.1.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.2.2.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.2.3.China Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.3.Japan

10.3.1.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.3.2.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.3.3.Japan Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.4.India

10.4.1.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.4.2.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.4.3.India Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.5.Australia

10.5.1.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.5.2.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.5.3.Australia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.6.South Korea

10.6.1.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.6.2.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.6.3.South Korea Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.7.Rest of Asia-Pacific

10.7.1.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

10.7.2.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

10.7.3.Rest of Asia-Pacific Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

10.8.Asia Pacific PEST Analysis

CHAPTER 11.Latin America Platelet and Plasma Market By Country

11.1.Latin America Platelet and Plasma Market Overview

11.2.Brazil

11.2.1.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

11.2.2.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

11.2.3.Brazil Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

11.3.Mexico

11.3.1.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

11.3.2.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

11.3.3.Mexico Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

11.4.Rest of Latin America

11.4.1.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

11.4.2.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2016 – 2027

11.4.3.Rest of Latin America Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

CHAPTER 12.Middle East & Africa Platelet and Plasma Market By Country 

12.1.Middle East & Africa Platelet and Plasma Market Overview

12.2.Saudi Arabia

12.2.1.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

12.2.2.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

12.2.3.Saudi Arabia Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

12.3.UAE

12.3.1.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

12.3.2.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

12.3.3.UAE Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

12.4.Rest of Middle East & Africa

12.4.1.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Component, 2017 - 2028

12.4.2.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Distribution Channel, 2017 - 2028

12.4.3.Rest of Middle East & Africa Platelet and Plasma Market Revenue (US$ Mn) and Forecast By Application, 2017 - 2028

CHAPTER 13.Player Analysis Of Platelet and Plasma

13.1.Platelet and Plasma Market Company Share Analysis

13.2.Competition Matrix

13.2.1.Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2.New Product Launches and Product Enhancements

13.2.3.Mergers And Acquisition In Global Platelet and Plasma Market

13.2.4.Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14.COMPANY PROFILE

14.1.Spanish Red Cross

14.1.1.Company Snapshot

14.1.2.Business Overview

14.1.3.Financial Overview

14.1.3.1.Revenue (US$ Mn), 2020

14.1.3.2.Spanish Red Cross 2020 Platelet and Plasma Business Regional Distribution

14.1.4.Product/ Service and Specification

14.1.5.Recent Developments & Business Strategy

14.1.6.Manufacturing Plant Footprint Analysis

14.2.American Red Cross

14.3.America’s Blood Centers

14.4.Blood Centers of America

14.5.European Blood Alliance

14.6.Indian Red Cross Society

14.7.Japanese Red Cross Society

14.8.Red Cross Society of China

14.9.Saudi Red

14.10.Crescent Authority

14.11.Arthrex, Inc.

14.12.South Africa Red Cross Society.

14.13.AdiStem Ltd. 

14.14.Others

Frequently Asked Questions

What will be the market value of platelet and plasma in 2027?

The market value of platelet and plasma is anticipated to be around US$ 8,000 Mn in 2027.

What will be the CAGR of platelet and plasma market?

It is anticipated to grow around 3% CAGR amid the forecast period 2020-2027

Which region held the maximum share of the platelet and plasma market?

North America held maximum share in 2019.

Which region is projected to grow at a fastest rate during the forecast period?

Europe is projected to grow at a fast pace during forecast period from 2020-2027.

What is the main driver of platelet and plasma market?

Increasing prevalence of liver diseases in elderly population is expected to drive the growth of the platelet and plasma market.

Which factor restrains the growth of platelet and plasma market?

Stringent regulatory policies are a major factor expected to restraint the growth of the market.

Which are the prominent players in the platelet and plasma market?

Spanish Red Cross, American Red Cross, America’s Blood Centers, Blood Centers of America, European Blood Alliance, Indian Red Cross Society, Japanese Red Cross Society, Red Cross Society of China, Saudi Red, Crescent Authority, Arthrex, Inc., South Africa Red Cross Society., AdiStem Ltd., and others are the prominent players in the platelet and plasma market.

Select Licence Type

Single User

US$ 4500

Multi User

US$ 7000

Excel Datapack

US$ 2000

Why Acumen Research And Consulting

100%

Customer Satisfaction

24x7

Availability - we are always there when you need us

200+

Fortune 50 Companies trust Acumen Research and Consulting

80%

of our reports are exclusive and first in the industry

100%

more data and analysis

1000+

reports published till date